Johnson and Johnson announces increase in sales

Johnson and Johnson revealed its financial results this week, which show a nine per cent increase in sales during the fourth quarter of 2009, compared to the corresponding period of the previous year.

The pharmacy supplier’s international sales rose by 15.6 per cent, something the firm associates with an operational growth of 6.4 per cent and a positive currency impact of 9.2 per cent.

For the full financial year, the group’s worldwide sales hit $61.9 billion (38.8 billion pounds).

William Weldon, chairman and chief executive officer of the organisation, stated that the firm has managed to deliver positive results in the face of a “tremendous challenge”.

He added: “We made important investments in acquisitions, strategic partnerships and launches of recently-approved innovative products while preserving our financial flexibility to continue to invest in innovation.”

In January, Johnson and Johnson company PriCara launched PrescribeResponsibly.com – a website addressing the appropriate prescription of pain management products.